Buy or sell Seven Bridges stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Seven Bridges Stock

Biomedical Data Science Company

Founded

2009

Notable Investors

Kryssen Capital

Headquarters

Charlestown MA, US

Total Funding

$113M

About Seven Bridges Stock

Seven Bridges is the industry-leading infrastructure and data analytics company accelerating precision medicine by enabling the understanding of biomedical data. Our platform, services, and support expertise are driving discovery and drug development at the world’s leading academic, biotechnology, government, hospitals, and pharmaceutical entities. Through our collaborations with the largest genomics projects, we connect the world’s biomedical information to enable the most efficient analysis at scale. Named one of the world's smartest companies by MIT Technology Review, and a three-time Bio-IT World Best of Show winner, Seven Bridges has offices in Belgrade, Boston, Istanbul, and San Francisco.

Investors

First Star Ventures

Seven Bridges

Kryssen Capital

Seven Bridges

Funding History

September 2014$3.0M
February 2016$45.0M
April 2018$50.0M
April 2021$15.0M

Management

Chief Executive Officer

William Moss

Chief Financial Officer

Robert Shay

Chief Technology Officer

David Ramos

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Seven Bridges or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 260K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo